← All trials
NCT05107219
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 17, 2022
- Primary completion
- Sep 1, 2024
- Completion date
- Sep 1, 2024
- First posted
- Nov 4, 2021
- Last posted
- Nov 9, 2021
- Enrollment
- 39
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Cancer Institute (NCI)Lead sponsor
- Temple UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.